SenesTech (NASDAQ:SNES) Coverage Initiated by Analysts at StockNews.com

Research analysts at StockNews.com started coverage on shares of SenesTech (NASDAQ:SNESGet Free Report) in a report released on Thursday. The firm set a “sell” rating on the stock.

Separately, HC Wainwright reissued a “buy” rating and issued a $3.50 price target on shares of SenesTech in a report on Tuesday, May 14th.

Read Our Latest Research Report on SenesTech

SenesTech Price Performance

NASDAQ:SNES opened at $0.50 on Thursday. The company has a debt-to-equity ratio of 0.03, a current ratio of 6.91 and a quick ratio of 5.69. SenesTech has a one year low of $0.50 and a one year high of $14.04. The firm has a 50-day moving average of $0.70 and a 200-day moving average of $0.83.

SenesTech (NASDAQ:SNESGet Free Report) last announced its quarterly earnings results on Thursday, May 9th. The company reported ($0.36) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.34) by ($0.02). SenesTech had a negative return on equity of 181.46% and a negative net margin of 545.82%. The company had revenue of $0.42 million for the quarter, compared to the consensus estimate of $0.43 million. During the same quarter last year, the company posted ($15.85) EPS. As a group, analysts anticipate that SenesTech will post -1.1 earnings per share for the current fiscal year.

Hedge Funds Weigh In On SenesTech

A hedge fund recently bought a new stake in SenesTech stock. McAdam LLC bought a new stake in SenesTech, Inc. (NASDAQ:SNESFree Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 64,348 shares of the company’s stock, valued at approximately $44,000. McAdam LLC owned about 1.25% of SenesTech as of its most recent SEC filing. 5.19% of the stock is owned by institutional investors.

SenesTech Company Profile

(Get Free Report)

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Read More

Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.